Funded Tech Companies
Viamet Pharmaceuticals
Wondering who provided funding to Viamet Pharmaceuticals? Private investors, Lilly Ventures and Astellas Venture Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Viamet Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
4505 Emperor Blvd. 300
Durham, NC 27703
USA
Durham, NC 27703
USA
Phone
Website
Email Address
Not Recorded
Company Background Information
Overview
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/29/2016
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Schotzinger
Chief Medical Officer
Oren Cohen
VP - Product Management
Thorsten Degenhardt
Company Investors
- Lilly Ventures (Edward Torres)
- Astellas Venture Capital
- Novartis Venture Fund (Lauren Silverman)
- Brandon Capital Partners (Adrian Howd)
- Hatteras Venture Partners (Douglas Reed)
- Woodford Investment Management
- Intersouth Partners (James Rosen)
- Lurie Investments
- Lilly Ventures (Ed Torres)
- Lurie Investments (William White)
- Intersouth Partners (Garheng Kong)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs